| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| CRL - Creightons Plc | SELL | -28 @ USD 105.92 | USD -2,966 | The ETF sold 28 shares of CRL on 2025-04-15. The shares were previously bought for an average price of USD 171.177. The Creightons Plc shares were sold for -38.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,827 The average price that the ETF previously sold CRL share for is USD 194.049 which is higher than the selling price of USD 105.92 on 2025-04-15. |
| DVA - DaVita HealthCare Partners Inc | SELL | -25 @ USD 146.28 | USD -3,657 | The ETF sold 25 shares of DVA on 2025-04-15. The shares were previously bought for an average price of USD 156.212. The DaVita HealthCare Partners Inc shares were sold for -6.4% lower than average price of previous purchases. This resulted in an overall loss of USD 248 The average price that the ETF previously sold DVA share for is USD 155.097 which is higher than the selling price of USD 146.28 on 2025-04-15. |
| HSIC - Henry Schein Inc | SELL | -69 @ USD 64.28 | USD -4,435 | The ETF sold 69 shares of HSIC on 2025-04-15. The shares were previously bought for an average price of USD 73.4903. The Henry Schein Inc shares were sold for -12.5% lower than average price of previous purchases. This resulted in an overall loss of USD 636 The average price that the ETF previously sold HSIC share for is USD 71.8921 which is higher than the selling price of USD 64.28 on 2025-04-15. |
| TECH - Bio-Techne Corp | SELL | -87 @ USD 51.07 | USD -4,443 | The ETF sold 87 shares of TECH on 2025-04-15. The shares were previously bought for an average price of USD 67.0223. The Bio-Techne Corp shares were sold for -23.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,388 The average price that the ETF previously sold TECH share for is USD 71.6642 which is higher than the selling price of USD 51.07 on 2025-04-15. |
| MRNA - Moderna Inc | SELL | -184 @ USD 26.24 | USD -4,828 | The ETF sold 184 shares of MRNA on 2025-04-15. The shares were previously bought for an average price of USD 36.4077. The Moderna Inc shares were sold for -27.9% lower than average price of previous purchases. This resulted in an overall loss of USD 1,871 The average price that the ETF previously sold MRNA share for is USD 42.5125 which is higher than the selling price of USD 26.24 on 2025-04-15. |
| SOLV - Solventum Corp. | SELL | -74 @ USD 65.93 | USD -4,879 | The ETF sold 74 shares of SOLV on 2025-04-15. The shares were previously bought for an average price of USD 74.7865. The Solventum Corp. shares were sold for -11.8% lower than average price of previous purchases. This resulted in an overall loss of USD 655 The average price that the ETF previously sold SOLV share for is USD 71.379 which is higher than the selling price of USD 65.93 on 2025-04-15. |
| VTRS - Viatris Inc | SELL | -669 @ USD 7.48 | USD -5,004 | The ETF sold 669 shares of VTRS on 2025-04-15. The shares were previously bought for an average price of USD 10.5684. The Viatris Inc shares were sold for -29.2% lower than average price of previous purchases. This resulted in an overall loss of USD 2,066 The average price that the ETF previously sold VTRS share for is USD 12.3079 which is higher than the selling price of USD 7.48 on 2025-04-15. |
| INCY - Incyte Corporation | SELL | -89 @ USD 58.46 | USD -5,203 | The ETF sold 89 shares of INCY on 2025-04-15. The shares were previously bought for an average price of USD 69.7854. The Incyte Corporation shares were sold for -16.2% lower than average price of previous purchases. This resulted in an overall loss of USD 1,008 The average price that the ETF previously sold INCY share for is USD 74.0822 which is higher than the selling price of USD 58.46 on 2025-04-15. |
| UHS - Universal Health Services Inc | SELL | -31 @ USD 175.5 | USD -5,441 | The ETF sold 31 shares of UHS on 2025-04-15. The shares were previously bought for an average price of USD 190.165. The Universal Health Services Inc shares were sold for -7.7% lower than average price of previous purchases. This resulted in an overall loss of USD 455 The average price that the ETF previously sold UHS share for is USD 196.461 which is higher than the selling price of USD 175.5 on 2025-04-15. |
| ALGN - Align Technology Inc | SELL | -39 @ USD 164.15 | USD -6,402 | The ETF sold 39 shares of ALGN on 2025-04-15. The shares were previously bought for an average price of USD 190.424. The Align Technology Inc shares were sold for -13.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,025 The average price that the ETF previously sold ALGN share for is USD 219.092 which is higher than the selling price of USD 164.15 on 2025-04-15. |
| RVTY - Revvity Inc. | SELL | -68 @ USD 95.54 | USD -6,497 | The ETF sold 68 shares of RVTY on 2025-04-15. The shares were previously bought for an average price of USD 113.763. The Revvity Inc. shares were sold for -16.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,239 The average price that the ETF previously sold RVTY share for is USD 115.984 which is higher than the selling price of USD 95.54 on 2025-04-15. |
| HOLX - Hologic Inc | SELL | -124 @ USD 57.86 | USD -7,175 | The ETF sold 124 shares of HOLX on 2025-04-15. The shares were previously bought for an average price of USD 67.8373. The Hologic Inc shares were sold for -14.7% lower than average price of previous purchases. This resulted in an overall loss of USD 1,237 The average price that the ETF previously sold HOLX share for is USD 73.0497 which is higher than the selling price of USD 57.86 on 2025-04-15. |
| BAX - Baxter International Inc | SELL | -280 @ USD 27.8 | USD -7,784 | The ETF sold 280 shares of BAX on 2025-04-15. The shares were previously bought for an average price of USD 33.5164. The Baxter International Inc shares were sold for -17.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,601 The average price that the ETF previously sold BAX share for is USD 33.3952 which is higher than the selling price of USD 27.8 on 2025-04-15. |
| WST - West Pharmaceutical Services Inc | SELL | -39 @ USD 212.5 | USD -8,288 | The ETF sold 39 shares of WST on 2025-04-15. The shares were previously bought for an average price of USD 264.303. The West Pharmaceutical Services Inc shares were sold for -19.6% lower than average price of previous purchases. This resulted in an overall loss of USD 2,020 The average price that the ETF previously sold WST share for is USD 303.363 which is higher than the selling price of USD 212.5 on 2025-04-15. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -112 @ USD 77.8 | USD -8,714 | The ETF sold 112 shares of COO on 2025-04-15. The shares were previously bought for an average price of USD 89.8782. The The Cooper Companies, Inc. Common Stock shares were sold for -13.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,353 The average price that the ETF previously sold COO share for is USD 98.3765 which is higher than the selling price of USD 77.8 on 2025-04-15. |
| BIIB - Biogen Inc | SELL | -80 @ USD 116.98 | USD -9,358 | The ETF sold 80 shares of BIIB on 2025-04-15. The shares were previously bought for an average price of USD 147.936. The Biogen Inc shares were sold for -20.9% lower than average price of previous purchases. This resulted in an overall loss of USD 2,476 The average price that the ETF previously sold BIIB share for is USD 160.662 which is higher than the selling price of USD 116.98 on 2025-04-15. |
| PODD - Insulet Corporation | SELL | -38 @ USD 256.425 | USD -9,744 | The ETF sold 38 shares of PODD on 2025-04-15. The shares were previously bought for an average price of USD 269.561. The Insulet Corporation shares were sold for -4.9% lower than average price of previous purchases. This resulted in an overall loss of USD 499 The average price that the ETF previously sold PODD share for is USD 261.901 which is higher than the selling price of USD 256.425 on 2025-04-15. |
| MOH - MOH | SELL | -30 @ USD 335.5 | USD -10,065 | The ETF sold 30 shares of MOH on 2025-04-15. The shares were previously bought for an average price of USD 307.818. The MOH shares were sold for 9.0% higher than average price of previous purchases. This sale made a profit of USD 830 The average price that the ETF previously sold MOH share for is USD 313.144 so the ETF has sold 30 shares on 2025-04-15 at a higher price than the previous selling average. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -30 @ USD 335.5 | USD -10,065 | The ETF sold 30 shares of MOH on 2025-04-15. The shares were previously bought for an average price of USD 307.818. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for 9.0% higher than average price of previous purchases. This sale made a profit of USD 830 The average price that the ETF previously sold MOH share for is USD 313.144 so the ETF has sold 30 shares on 2025-04-15 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -45 @ USD 226.02 | USD -10,171 | The ETF sold 45 shares of LH on 2025-04-15. The shares were previously bought for an average price of USD 241.657. The Laboratory Corporation of America Holdings shares were sold for -6.5% lower than average price of previous purchases. This resulted in an overall loss of USD 704 The average price that the ETF previously sold LH share for is USD 237.838 which is higher than the selling price of USD 226.02 on 2025-04-15. |
| WAT - Waters Corporation | SELL | -32 @ USD 323.44 | USD -10,350 | The ETF sold 32 shares of WAT on 2025-04-15. The shares were previously bought for an average price of USD 373.416. The Waters Corporation shares were sold for -13.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,599 The average price that the ETF previously sold WAT share for is USD 375.032 which is higher than the selling price of USD 323.44 on 2025-04-15. |
| WAT - MULETFWATIMETFP | SELL | -32 @ USD 323.44 | USD -10,350 | The ETF sold 32 shares of WAT on 2025-04-15. The shares were previously bought for an average price of USD 373.416. The MULETFWATIMETFP shares were sold for -13.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,599 The average price that the ETF previously sold WAT share for is USD 375.032 which is higher than the selling price of USD 323.44 on 2025-04-15. |
| DGX - Quest Diagnostics Incorporated | SELL | -62 @ USD 167.23 | USD -10,368 | The ETF sold 62 shares of DGX on 2025-04-15. The shares were previously bought for an average price of USD 165.734. The Quest Diagnostics Incorporated shares were sold for 0.9% higher than average price of previous purchases. This sale made a profit of USD 93 The average price that the ETF previously sold DGX share for is USD 160.997 so the ETF has sold 62 shares on 2025-04-15 at a higher price than the previous selling average. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -109 @ USD 97.27 | USD -10,602 | The ETF sold 109 shares of ZBH on 2025-04-15. The shares were previously bought for an average price of USD 107.997. The Zimmer Biomet Holdings Inc shares were sold for -9.9% lower than average price of previous purchases. This resulted in an overall loss of USD 1,169 The average price that the ETF previously sold ZBH share for is USD 109.039 which is higher than the selling price of USD 97.27 on 2025-04-15. |
| MTD - Mettler-Toledo International Inc | SELL | -11 @ USD 1046.58 | USD -11,512 | The ETF sold 11 shares of MTD on 2025-04-15. The shares were previously bought for an average price of USD 1258.05. The Mettler-Toledo International Inc shares were sold for -16.8% lower than average price of previous purchases. This resulted in an overall loss of USD 2,326 The average price that the ETF previously sold MTD share for is USD 1251.09 which is higher than the selling price of USD 1046.58 on 2025-04-15. |
| MTD - AMUNDI EUR GOV 710 | SELL | -11 @ USD 1046.58 | USD -11,512 | The ETF sold 11 shares of MTD on 2025-04-15. The shares were previously bought for an average price of USD 1258.05. The AMUNDI EUR GOV 710 shares were sold for -16.8% lower than average price of previous purchases. This resulted in an overall loss of USD 2,326 The average price that the ETF previously sold MTD share for is USD 1251.09 which is higher than the selling price of USD 1046.58 on 2025-04-15. |
| STE - STERIS plc | SELL | -54 @ USD 221.04 | USD -11,936 | The ETF sold 54 shares of STE on 2025-04-15. The shares were previously bought for an average price of USD 221.717. The STERIS plc shares were sold for -0.3% lower than average price of previous purchases. This resulted in an overall loss of USD 37 The average price that the ETF previously sold STE share for is USD 217.91 so the ETF has sold 54 shares on 2025-04-15 at a higher price than the previous selling average. |
| IQV - IQVIA Holdings Inc | SELL | -92 @ USD 149.15 | USD -13,722 | The ETF sold 92 shares of IQV on 2025-04-15. The shares were previously bought for an average price of USD 196.411. The IQVIA Holdings Inc shares were sold for -24.1% lower than average price of previous purchases. This resulted in an overall loss of USD 4,348 The average price that the ETF previously sold IQV share for is USD 200.486 which is higher than the selling price of USD 149.15 on 2025-04-15. |
| DXCM - DexCom Inc | SELL | -216 @ USD 69.23 | USD -14,954 | The ETF sold 216 shares of DXCM on 2025-04-15. The shares were previously bought for an average price of USD 78.5289. The DexCom Inc shares were sold for -11.8% lower than average price of previous purchases. This resulted in an overall loss of USD 2,009 The average price that the ETF previously sold DXCM share for is USD 74.0459 which is higher than the selling price of USD 69.23 on 2025-04-15. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -250 @ USD 63.1 | USD -15,775 | The ETF sold 250 shares of GEHC on 2025-04-15. The shares were previously bought for an average price of USD 86.443. The GE HealthCare Technologies Inc. shares were sold for -27.0% lower than average price of previous purchases. This resulted in an overall loss of USD 5,836 The average price that the ETF previously sold GEHC share for is USD 82.6542 which is higher than the selling price of USD 63.1 on 2025-04-15. |
| A - Agilent Technologies Inc | SELL | -156 @ USD 103.12 | USD -16,087 | The ETF sold 156 shares of A on 2025-04-15. The shares were previously bought for an average price of USD 131.964. The Agilent Technologies Inc shares were sold for -21.9% lower than average price of previous purchases. This resulted in an overall loss of USD 4,500 The average price that the ETF previously sold A share for is USD 133.517 which is higher than the selling price of USD 103.12 on 2025-04-15. |
| RMD - ResMed Inc | SELL | -80 @ USD 213.97 | USD -17,118 | The ETF sold 80 shares of RMD on 2025-04-15. The shares were previously bought for an average price of USD 235.04. The ResMed Inc shares were sold for -9.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,686 The average price that the ETF previously sold RMD share for is USD 243.097 which is higher than the selling price of USD 213.97 on 2025-04-15. |
| CNC - Concurrent Technologies Plc | SELL | -275 @ USD 62.28 | USD -17,127 | The ETF sold 275 shares of CNC on 2025-04-15. The shares were previously bought for an average price of USD 60.1823. The Concurrent Technologies Plc shares were sold for 3.5% higher than average price of previous purchases. This sale made a profit of USD 577 The average price that the ETF previously sold CNC share for is USD 59.8129 so the ETF has sold 275 shares on 2025-04-15 at a higher price than the previous selling average. |
| IDXX - IDEXX Laboratories Inc | SELL | -44 @ USD 404.02 | USD -17,777 | The ETF sold 44 shares of IDXX on 2025-04-15. The shares were previously bought for an average price of USD 438.202. The IDEXX Laboratories Inc shares were sold for -7.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,504 The average price that the ETF previously sold IDXX share for is USD 429.08 which is higher than the selling price of USD 404.02 on 2025-04-15. |
| CAH - Cardinal Health Inc | SELL | -133 @ USD 134.25 | USD -17,855 | The ETF sold 133 shares of CAH on 2025-04-15. The shares were previously bought for an average price of USD 127.212. The Cardinal Health Inc shares were sold for 5.5% higher than average price of previous purchases. This sale made a profit of USD 936 The average price that the ETF previously sold CAH share for is USD 122.239 so the ETF has sold 133 shares on 2025-04-15 at a higher price than the previous selling average. |
| HUM - Hummingbird Resources PLC | SELL | -65 @ USD 286.78 | USD -18,641 | The ETF sold 65 shares of HUM on 2025-04-15. The shares were previously bought for an average price of USD 272.131. The Hummingbird Resources PLC shares were sold for 5.4% higher than average price of previous purchases. This sale made a profit of USD 952 The average price that the ETF previously sold HUM share for is USD 282.893 so the ETF has sold 65 shares on 2025-04-15 at a higher price than the previous selling average. |
| HUM - Humana Inc | SELL | -65 @ USD 286.78 | USD -18,641 | The ETF sold 65 shares of HUM on 2025-04-15. The shares were previously bought for an average price of USD 272.131. The Humana Inc shares were sold for 5.4% higher than average price of previous purchases. This sale made a profit of USD 952 The average price that the ETF previously sold HUM share for is USD 282.893 so the ETF has sold 65 shares on 2025-04-15 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -323 @ USD 70.76 | USD -22,855 | The ETF sold 323 shares of EW on 2025-04-15. The shares were previously bought for an average price of USD 71.0156. The Edwards Lifesciences Corp shares were sold for -0.4% lower than average price of previous purchases. This resulted in an overall loss of USD 83 The average price that the ETF previously sold EW share for is USD 69.3457 so the ETF has sold 323 shares on 2025-04-15 at a higher price than the previous selling average. |
| COR - Cencora Inc. | SELL | -94 @ USD 284.54 | USD -26,747 | The ETF sold 94 shares of COR on 2025-04-15. The shares were previously bought for an average price of USD 251.231. The Cencora Inc. shares were sold for 13.3% higher than average price of previous purchases. This sale made a profit of USD 3,131 The average price that the ETF previously sold COR share for is USD 248.345 so the ETF has sold 94 shares on 2025-04-15 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -157 @ USD 202.04 | USD -31,720 | The ETF sold 157 shares of BDX on 2025-04-15. The shares were previously bought for an average price of USD 231.159. The Becton Dickinson and Company shares were sold for -12.6% lower than average price of previous purchases. This resulted in an overall loss of USD 4,572 The average price that the ETF previously sold BDX share for is USD 225.603 which is higher than the selling price of USD 202.04 on 2025-04-15. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -57 @ USD 557.91 | USD -31,801 | The ETF sold 57 shares of REGN on 2025-04-15. The shares were previously bought for an average price of USD 714.539. The Regeneron Pharmaceuticals Inc shares were sold for -21.9% lower than average price of previous purchases. This resulted in an overall loss of USD 8,928 The average price that the ETF previously sold REGN share for is USD 769.939 which is higher than the selling price of USD 557.91 on 2025-04-15. |
| HCA - HCA Holdings Inc | SELL | -97 @ USD 335.55 | USD -32,548 | The ETF sold 97 shares of HCA on 2025-04-15. The shares were previously bought for an average price of USD 336.277. The HCA Holdings Inc shares were sold for -0.2% lower than average price of previous purchases. This resulted in an overall loss of USD 71 The average price that the ETF previously sold HCA share for is USD 335.539 so the ETF has sold 97 shares on 2025-04-15 at a higher price than the previous selling average. |
| ZTS - Zoetis Inc | SELL | -244 @ USD 149.22 | USD -36,410 | The ETF sold 244 shares of ZTS on 2025-04-15. The shares were previously bought for an average price of USD 168.289. The Zoetis Inc shares were sold for -11.3% lower than average price of previous purchases. This resulted in an overall loss of USD 4,653 The average price that the ETF previously sold ZTS share for is USD 174.989 which is higher than the selling price of USD 149.22 on 2025-04-15. |
| MCK - McKesson Corporation | SELL | -68 @ USD 692.86 | USD -47,114 | The ETF sold 68 shares of MCK on 2025-04-15. The shares were previously bought for an average price of USD 612.44. The McKesson Corporation shares were sold for 13.1% higher than average price of previous purchases. This sale made a profit of USD 5,469 The average price that the ETF previously sold MCK share for is USD 610.781 so the ETF has sold 68 shares on 2025-04-15 at a higher price than the previous selling average. |
| CVS - CVS Health Corp | SELL | -687 @ USD 68.92 | USD -47,348 | The ETF sold 687 shares of CVS on 2025-04-15. The shares were previously bought for an average price of USD 62.1919. The CVS Health Corp shares were sold for 10.8% higher than average price of previous purchases. This sale made a profit of USD 4,622 The average price that the ETF previously sold CVS share for is USD 57.9561 so the ETF has sold 687 shares on 2025-04-15 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -149 @ USD 328.63 | USD -48,966 | The ETF sold 149 shares of CI on 2025-04-15. The shares were previously bought for an average price of USD 313.959. The Cigna Corp shares were sold for 4.7% higher than average price of previous purchases. This sale made a profit of USD 2,186 The average price that the ETF previously sold CI share for is USD 322.61 so the ETF has sold 149 shares on 2025-04-15 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -125 @ USD 437.77 | USD -54,721 | The ETF sold 125 shares of ELV on 2025-04-15. The shares were previously bought for an average price of USD 409.68. The Elevance Health Inc shares were sold for 6.9% higher than average price of previous purchases. This sale made a profit of USD 3,511 The average price that the ETF previously sold ELV share for is USD 410.644 so the ETF has sold 125 shares on 2025-04-15 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -125 @ USD 437.77 | USD -54,721 | The ETF sold 125 shares of ELV on 2025-04-15. The shares were previously bought for an average price of USD 409.68. The Elevance Health Inc shares were sold for 6.9% higher than average price of previous purchases. This sale made a profit of USD 3,511 The average price that the ETF previously sold ELV share for is USD 410.644 so the ETF has sold 125 shares on 2025-04-15 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -1,105 @ USD 50 | USD -55,250 | The ETF sold 1105 shares of BMY on 2025-04-15. The shares were previously bought for an average price of USD 58.1196. The Bloomsbury Publishing Plc shares were sold for -14.0% lower than average price of previous purchases. This resulted in an overall loss of USD 8,972 The average price that the ETF previously sold BMY share for is USD 57.0285 which is higher than the selling price of USD 50 on 2025-04-15. |
| MDT - Medtronic PLC | SELL | -698 @ USD 82.37 | USD -57,494 | The ETF sold 698 shares of MDT on 2025-04-15. The shares were previously bought for an average price of USD 89.1446. The Medtronic PLC shares were sold for -7.6% lower than average price of previous purchases. This resulted in an overall loss of USD 4,729 The average price that the ETF previously sold MDT share for is USD 86.706 which is higher than the selling price of USD 82.37 on 2025-04-15. |
| SYK - Stryker Corporation | SELL | -186 @ USD 346.8 | USD -64,505 | The ETF sold 186 shares of SYK on 2025-04-15. The shares were previously bought for an average price of USD 380.929. The Stryker Corporation shares were sold for -9.0% lower than average price of previous purchases. This resulted in an overall loss of USD 6,348 The average price that the ETF previously sold SYK share for is USD 378.67 which is higher than the selling price of USD 346.8 on 2025-04-15. |
| DHR - Danaher Corporation | SELL | -348 @ USD 189.92 | USD -66,092 | The ETF sold 348 shares of DHR on 2025-04-15. The shares were previously bought for an average price of USD 219.847. The Danaher Corporation shares were sold for -13.6% lower than average price of previous purchases. This resulted in an overall loss of USD 10,415 The average price that the ETF previously sold DHR share for is USD 234.13 which is higher than the selling price of USD 189.92 on 2025-04-15. |
| DHR - Danaher Corporation | SELL | -348 @ USD 189.92 | USD -66,092 | The ETF sold 348 shares of DHR on 2025-04-15. The shares were previously bought for an average price of USD 219.847. The Danaher Corporation shares were sold for -13.6% lower than average price of previous purchases. This resulted in an overall loss of USD 10,415 The average price that the ETF previously sold DHR share for is USD 234.13 which is higher than the selling price of USD 189.92 on 2025-04-15. |
| PFE - Pfizer Inc | SELL | -3,083 @ USD 22.44 | USD -69,183 | The ETF sold 3083 shares of PFE on 2025-04-15. The shares were previously bought for an average price of USD 26.0678. The Pfizer Inc shares were sold for -13.9% lower than average price of previous purchases. This resulted in an overall loss of USD 11,185 The average price that the ETF previously sold PFE share for is USD 25.9731 which is higher than the selling price of USD 22.44 on 2025-04-15. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -139 @ USD 500.49 | USD -69,568 | The ETF sold 139 shares of VRTX on 2025-04-15. The shares were previously bought for an average price of USD 477.045. The Vertex Pharmaceuticals Inc shares were sold for 4.9% higher than average price of previous purchases. This sale made a profit of USD 3,259 The average price that the ETF previously sold VRTX share for is USD 480.753 so the ETF has sold 139 shares on 2025-04-15 at a higher price than the previous selling average. |
| GILD - Guild Esports Plc | SELL | -678 @ USD 105.68 | USD -71,651 | The ETF sold 678 shares of GILD on 2025-04-15. The shares were previously bought for an average price of USD 102.556. The Guild Esports Plc shares were sold for 3.0% higher than average price of previous purchases. This sale made a profit of USD 2,118 The average price that the ETF previously sold GILD share for is USD 94.6519 so the ETF has sold 678 shares on 2025-04-15 at a higher price than the previous selling average. |
| BSX - Boston Scientific Corporation | SELL | -802 @ USD 94.23 | USD -75,572 | The ETF sold 802 shares of BSX on 2025-04-15. The shares were previously bought for an average price of USD 98.4985. The Boston Scientific Corporation shares were sold for -4.3% lower than average price of previous purchases. This resulted in an overall loss of USD 3,423 The average price that the ETF previously sold BSX share for is USD 90.0747 so the ETF has sold 802 shares on 2025-04-15 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -802 @ USD 94.23 | USD -75,572 | The ETF sold 802 shares of BSX on 2025-04-15. The shares were previously bought for an average price of USD 98.4985. The MULSTRXSSXIMETFP shares were sold for -4.3% lower than average price of previous purchases. This resulted in an overall loss of USD 3,423 The average price that the ETF previously sold BSX share for is USD 90.0747 so the ETF has sold 802 shares on 2025-04-15 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -292 @ USD 295.3 | USD -86,228 | The ETF sold 292 shares of AMGN on 2025-04-15. The shares were previously bought for an average price of USD 304.248. The Amgen Inc shares were sold for -2.9% lower than average price of previous purchases. This resulted in an overall loss of USD 2,613 The average price that the ETF previously sold AMGN share for is USD 297.834 which is higher than the selling price of USD 295.3 on 2025-04-15. |
| TMO - Time Out Group plc | SELL | -208 @ USD 441 | USD -91,728 | The ETF sold 208 shares of TMO on 2025-04-15. The shares were previously bought for an average price of USD 532.898. The Time Out Group plc shares were sold for -17.2% lower than average price of previous purchases. This resulted in an overall loss of USD 19,115 The average price that the ETF previously sold TMO share for is USD 528.27 which is higher than the selling price of USD 441 on 2025-04-15. |
| ISRG - Intuitive Surgical Inc | SELL | -193 @ USD 488.27 | USD -94,236 | The ETF sold 193 shares of ISRG on 2025-04-15. The shares were previously bought for an average price of USD 546.225. The Intuitive Surgical Inc shares were sold for -10.6% lower than average price of previous purchases. This resulted in an overall loss of USD 11,185 The average price that the ETF previously sold ISRG share for is USD 531.51 which is higher than the selling price of USD 488.27 on 2025-04-15. |
| MRK - Marks Electrical Group PLC | SELL | -1,375 @ USD 78.39 | USD -107,786 | The ETF sold 1375 shares of MRK on 2025-04-15. The shares were previously bought for an average price of USD 93.1573. The Marks Electrical Group PLC shares were sold for -15.9% lower than average price of previous purchases. This resulted in an overall loss of USD 20,305 The average price that the ETF previously sold MRK share for is USD 99.8047 which is higher than the selling price of USD 78.39 on 2025-04-15. |
| MRK - Merck & Company Inc | SELL | -1,375 @ USD 78.39 | USD -107,786 | The ETF sold 1375 shares of MRK on 2025-04-15. The shares were previously bought for an average price of USD 93.1573. The Merck & Company Inc shares were sold for -15.9% lower than average price of previous purchases. This resulted in an overall loss of USD 20,305 The average price that the ETF previously sold MRK share for is USD 99.8047 which is higher than the selling price of USD 78.39 on 2025-04-15. |
| ABT - Abbott Laboratories | SELL | -942 @ USD 126.22 | USD -118,899 | The ETF sold 942 shares of ABT on 2025-04-15. The shares were previously bought for an average price of USD 126.267. The Abbott Laboratories shares were sold for 0.0% lower than average price of previous purchases. This resulted in an overall loss of USD 44 The average price that the ETF previously sold ABT share for is USD 118.138 so the ETF has sold 942 shares on 2025-04-15 at a higher price than the previous selling average. |
| ABBV - AbbVie Inc | SELL | -958 @ USD 176.8 | USD -169,374 | The ETF sold 958 shares of ABBV on 2025-04-15. The shares were previously bought for an average price of USD 193.27. The AbbVie Inc shares were sold for -8.5% lower than average price of previous purchases. This resulted in an overall loss of USD 15,778 The average price that the ETF previously sold ABBV share for is USD 186.779 which is higher than the selling price of USD 176.8 on 2025-04-15. |
| JNJ - Johnson & Johnson | SELL | -1,307 @ USD 153.62 | USD -200,781 | The ETF sold 1307 shares of JNJ on 2025-04-15. The shares were previously bought for an average price of USD 157.739. The Johnson & Johnson shares were sold for -2.6% lower than average price of previous purchases. This resulted in an overall loss of USD 5,384 The average price that the ETF previously sold JNJ share for is USD 154.838 which is higher than the selling price of USD 153.62 on 2025-04-15. |
| UNH - UnitedHealth Group Incorporated | SELL | -499 @ USD 583.59 | USD -291,211 | The ETF sold 499 shares of UNH on 2025-04-15. The shares were previously bought for an average price of USD 535.348. The UnitedHealth Group Incorporated shares were sold for 9.0% higher than average price of previous purchases. This sale made a profit of USD 24,073 The average price that the ETF previously sold UNH share for is USD 582.251 so the ETF has sold 499 shares on 2025-04-15 at a higher price than the previous selling average. |
| LLY - Eli Lilly and Company | SELL | -427 @ USD 757.18 | USD -323,316 | The ETF sold 427 shares of LLY on 2025-04-15. The shares were previously bought for an average price of USD 838.12. The Eli Lilly and Company shares were sold for -9.7% lower than average price of previous purchases. This resulted in an overall loss of USD 34,561 The average price that the ETF previously sold LLY share for is USD 801.543 which is higher than the selling price of USD 757.18 on 2025-04-15. |